Dr. Reddy's Laboratories (DRL) today said it launched Vozet Tablets in Indian market. The drug is indicated for the treatment of allergic Rhinitis and chronic Urticaria.
According to a press release issued by the city-based drug maker, Vozet Tablets contain Levocetirizine 5 mg, and are available in a strip size of 10 tablets.
The anti-histamine market in India had sales of Rs 1,038 crore MAT for the most recent twelve months ended in March 2017, according to IMS data.
Dr. Reddy's will further strengthen its anti-allergy portfolio with the addition of Vozet, it added.
DR Reddy's shares closed at Rs 2715.65 on BSE up 0.83 per cent compared to previous close even as the benchmark sensex closed at 31710.99 points down 1.13 per cent.
Disclaimer: No Business Standard Journalist was involved in creation of this content
